Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
(Total Views: 390)
Posted On: 04/03/2020 9:57:49 AM
Post# of 72446
Avatar
Posted By: Drano
Europe restricts chloroquine use to clinical trials or what we'd call "compassionate use." Concerns over whether it has efficacy, and if patients who need the drug and can't get it will not survive without it.

And here's a link to an exposé about the con-man French professor's completely bogus "study" of the drug. It sounds a lot like Dr. Stephen Smith's refusal to release the data behind his claims.

Quote:
In a Los Angeles Times column, writer Michael Hiltzik outlined flaws. In one of Raoult's studies, for example, six patients dropped out in the first six days; those patients either died, were transferred to the ICU, couldn't tolerate the drug, or dropped for another reason.

"Those six results, however, were not included in the results, meaning that Raoult 'cured' only 100% of those who didn’t get sicker, die, or leave the study," Hiltzik wrote.
https://www.latimes.com/business/story/2020-0...zik-column



Here's the article about Europe tightening restrictions on use of the drug:
https://www.fiercepharma.com/pharma/europe-lo...d=48083647













(4)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site